Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Coronavirus+disease+2019%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22Coronavirus+disease+2019%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22Coronavirus+disease+2019%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (120)
1
COMPASSIONATE COVID-19 TREATMENT PROJECT INTENDED TO EVALUATE SAFETY AND EFFICACY OF THE NIMRCAF, COVIDOL AND BUPIJI OIL – THE HERBAL PREPARATIONS FOR THE TREATMENT OF COVID-19 PATIENTS : COMPASSIONATE COVID-19 TREATMENT PROJECT INTENDED TO EVALUATE SAFETY AND EFFICACY OF THE NIMRCAF, COVIDOL AND BUPIJI OIL – THE HERBAL PREPARATIONS FOR THE TREATMENT OF COVID-19 PATIENTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
COMPASSIONATE COVID-19 TREATMENT PROJECT INTENDED TO EVALUATE SAFETY AND EFFICACY OF THE NIMRCAF, COVIDOL AND BUPIJI OIL – THE HERBAL PREPARATIONS FOR THE TREATMENT OF COVID-19 PATIENTS : COMPASSIONATE COVID-19 TREATMENT PROJECT INTENDED TO EVALUATE SAFETY AND EFFICACY OF THE NIMRCAF, COVIDOL AND BUPIJI OIL – THE HERBAL PREPARATIONS FOR THE TREATMENT OF COVID-19 PATIENTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP) : A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP) : A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients with Mild or Moderate COVID-19 : A PHASE II RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED STUDY TO EVALUATETHE ANTIVIRAL ACTIVITY, SAFETY,PHARMACOKINETICS, AND EFFICACY OFRO7496998 (AT-527) IN NON-HOSPITALIZED ADULT PATIENTS WITHMILD OR MODERATE COVID-19 - Phase II virology covid study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
A Phase 2/3 Efficacy And Safety Study Of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID 19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
A Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients with Mild or Moderate COVID-19 : A PHASE II RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED STUDY TO EVALUATETHE ANTIVIRAL ACTIVITY, SAFETY,PHARMACOKINETICS, AND EFFICACY OFRO7496998 (AT-527) IN NON-HOSPITALIZED ADULT PATIENTS WITHMILD OR MODERATE COVID-19 - Phase II virology covid study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
A Phase 2/3 Efficacy And Safety Study Of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID 19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) : A Virtual Phase 2 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Post-exposure Prophylaxis (PEP) for Newly-infected COVID-19 Patients
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) : A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of M5049 in Hospitalized Participants With COVID-19 Pneumonia (ANEMONE)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
120
Aufsätze
120
E-Artikel
120
E-Ressourcen
Zeitschriftentitel
110
WHO International Clinical Trials Registry Plat...
10
ClinicalTrials.gov
Thema
120
610
Phase: Phase 2
120
Study Type: Interventional
56
Recruitment Status: Not yet recruiting
52
Recruitment Status: Authorised-recruitment may ...
34
Medical Condition: COVID-19 MedDRA version: 23....
18
Medical Condition: Coronavirus Disease 2019 (CO...
12
Medical Condition: Coronavirus disease 2019 (CO...
10
Medical Condition: Moderate to severe coronavir...
8
COVID-19
7
Coronavirus Infections
5
Medical Condition: Coronavirus Disease 2019
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Recruitment Status: Completed
3
Medical Condition: Coronavirus Disease 2019 (CO...
2
Medical Condition: Acute coronavirus disease 20...
2
Medical Condition: Acute coronavirus disease 20...
2
Medical Condition: COVID-19 infection MedDRA ve...
2
Medical Condition: Coronavirus Disease 2019 (CO...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2023
57
2022
46
2021
13
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
118
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...